Community Dermatology Limited
Company Bio
Skin cancer rates continue to rise, especially in Western nations, which face higher-than-average incidence and long delays in dermatology pathways. Health systems are overwhelmed with benign skin lesions, often resulting in patients being referred to hospital unnecessarily. This results in long waiting lists for other inflammatory skin conditions as skin cancer cases take priority.
